Design Therapeutics, Inc.

NasdaqGS:DSGN 주식 보고서

시가총액: US$318.2m

Design Therapeutics 미래 성장

Future 기준 확인 0/6

Design Therapeutics 의 수익은 연간 17.7% 감소할 것으로 예상되는 반면, 연간 수익은 91.5% 로 증가할 것으로 예상됩니다. 91.5% 연간. EPS는 연간 15% 만큼 쇠퇴할 것으로 예상됩니다.

주요 정보

-17.7%

수익 성장률

-15.0%

EPS 성장률

Biotechs 수익 성장28.3%
매출 성장률91.5%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트08 Nov 2024

최근 미래 성장 업데이트

Recent updates

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Oct 04
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Jun 19
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Mar 15
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Nov 16
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Jun 06
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Feb 09
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Oct 25
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Design Therapeutics GAAP EPS of -$0.27 misses by $0.02

Aug 08

We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Jul 02
We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Mar 18
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Dec 03
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Aug 18
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics expands board of directors

Jun 07

Design Therapeutics EPS misses by $0.24

May 10

수익 및 매출 성장 예측

NasdaqGS:DSGN - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2026N/A-79N/AN/A3
12/31/2025N/A-67N/AN/A3
12/31/2024N/A-52N/AN/A3
9/30/2024N/A-48-46-46N/A
6/30/2024N/A-51-51-51N/A
3/31/2024N/A-59-54-54N/A
12/31/2023N/A-67-59-59N/A
9/30/2023N/A-72-61-61N/A
6/30/2023N/A-74-61-60N/A
3/31/2023N/A-69-58-57N/A
12/31/2022N/A-63-52-51N/A
9/30/2022N/A-57-46-45N/A
6/30/2022N/A-51-41-40N/A
3/31/2022N/A-43-39-38N/A
12/31/2021N/A-36-31-29N/A
9/30/20210-28-24-23N/A
6/30/20210-19-17-17N/A
3/31/20210-13-10-10N/A
12/31/20200-8-9-9N/A
12/31/20191-200N/A

애널리스트 미래 성장 예측

수입 대 저축률: DSGN 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: DSGN 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: DSGN 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: DSGN 은(는) 내년에 수익이 없을 것으로 예상됩니다.

고성장 수익: DSGN 은(는) 내년에 수익이 없을 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: DSGN 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견